– UK, London – Savills plc (LSE:SVS), the international real estate advisor, today announced the appointments of Stacey Cartwright and Florence Tondu-Melique as additional Independent Non-Executive Directors with effect from 1 October 2018.
Savills also announces that Charles McVeigh, who has served on the Board since 2000, will retire at the conclusion of the Company’s AGM in May 2019.
Commenting on the changes, Nicholas Ferguson, Chairman of Savills plc said : “We are delighted that Stacey and Florence are joining the Board so that Savills can benefit from their extensive experience. I also want to thank Charlie McVeigh very warmly for his enormous contribution to the Board over so many years”.
About Stacey Cartwright
Stacey Cartwright is currently the Senior Independent Director of the Football Association and was a non-executive director of GlaxoSmithKline plc from 2011 to 2016. Stacey is a chartered accountant and was previously Chief Executive (2014-17) and the Deputy Chairman (2017-18) of Harvey Nichols Group, before which she was Executive Vice President and CFO of Burberry Group plc (2004-13). Prior to 2004, Stacey was CFO of Egg plc having spent her early career with Granada Group plc.
About Florence Tondu-Melique
Florence Tondu-Melique is currently Chief Executive of Zurich France and a member of Zurich’s EMEA and Global Commercial Insurance Executive Committees. She was previously Chief Operating Officer of Hiscox Europe (2013-17), prior to which she was a Director at AXA Real Estate (2009-13) and AXA Investment Managers, which she joined in 2007. She spent her early career at McKinsey & Company.
For more information : http://www.savills.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
